Home » Closed Trials

Oral antimitotic agent for dogs with newly diagnosed lymphoma

21 May 2009 No Comment

Status: Closed 12/04
Eligibility:

* Measurable disease defined by examination, radiographs, ultra-sound, CT or MRI scan
* Cytologically diagnosed Non-Hodgkins Lymphoma (histology collected at study entry)
* Any clinical stage but must have nodal involvement
* No previous targeted therapy (including prednisone)

Trial Design:
Diagnostic and staging tests may be performed at any veterinary hospital within 10 days of initiation of study. Patients will be treated at Friendship Hospital for Animals. Lymph node biopsies will be required at entry and 7 and 21 days later.

Trial Support:
Study patients receive the oral anti-mitotic agent at no charge. Laboratory, biopsy and professional fees required for the study will be provided by the sponsor from time of enrollment.

Comments are closed.